Receive a free world-class investing education from MarketBeat. Reuters. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Arcturus Therapeutics Holdings Inc. (the Company, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The MarketWatch News Department was not involved in the creation of this content. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The biotech announced Monday … Currency in USD, Trade prices are not sourced from all markets, Make the World Smarter, Safer & Healthier. Arcturus Therapeutics, a publicly-traded company, is one of approximately 40 companies and organizations worldwide racing to develop a vaccine for the virus that to … On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. Get Arcturus Therapeutics Holdings Inc (ARCT:NASDAQ) real-time stock quotes, news and financial information from CNBC. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Arcturus Therapeutics to Present at Upcoming Investor Conference finance.yahoo.com - November 30 at 6:30 PM: Arcturus Therapeutics (NASDAQ:ARCT) Sets New 12-Month High at $71.50 americanbankingnews.com - November 27 at 11:47 AM: Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results. Export data to Excel for your own analysis. U.S. biotech firm Arcturus Therapeutics said it expects to start distributing its COVID-19 vaccine candidate in the first quarter of next year after early stage trials showed promising results. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get […]. The P/E ratio of Arcturus Therapeutics is -34.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. News Break App. Arcturus Therapeutics price target raised to $133 from $62 at Citi 12/08/20 B. Riley Securities Arcturus Therapeutics price target raised to $138 from $111 at B. Riley 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley 12/03/20 Piper Sandler Shares of Arcturus Therapeutics Holdings (NASDAQ:ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. By Reuters Staff. Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. Arcturus Therapeutics — $0.00 (0.00%) Today. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 What people call "the Pfizer drug" is actually the BioNTech drug, as it was the smaller biotech that actually found the molecule. Arcturus Therapeutics price target raised to $133 from $62 at Citi 12/08/20 B. Riley Securities Arcturus Therapeutics price target raised to $138 from $111 at B. Riley 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley 12/03/20 Piper Sandler Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at Piper Sandler’s 32 nd Annual Virtual Healthcare Conference: The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc , … Skip to content. Press Release reported on 09/08/20 that Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » ARCT. Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. They called the 2020 crash 45 days early. Please log in to your account or sign up in order to add this asset to your watchlist. Investors Brace for Barrage of Covid Vaccine Data to Roil Market, Hedge Fund-Pick Arcturus Gambles on a One-Shot Covid Vaccine, Why Arcturus Therapeutics Is Trading Higher Today, Arcturus advancing early-stage study of ARCT-810 in rare metabolic disorder, Arcturus Therapeutics completes first three dose escalation cohorts in early-stage ARCT-810, Amyloidosis Therapeutics Market Revenue Emerging Key Players Supply Demand Investment Feasibility and Forecast 2026 Worldwide, Familial Amyloid Polyneuropathy Therapeutics Market Analysis By Global COVID-19 Impact On Healthcare Sector, Receive Analysts' Upgrades and Downgrades Daily. Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020 SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc… In this article we will take a look at whether hedge funds think Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a good investment right now. All rights reserved. Arcturus Therapeutics shares traded up 13.03% to $48.36 on Monday. Learn more. Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data, Vallon Pharma Files For IPO Funding For ADHD Drug, IPO Preview: Vallon Pharmaceuticals Begins U.S. IPO Rollout, Vallon Pharmaceuticals Files For IPO Funding For ADHD Drug, Arcturus Progresses ARCT-810 Trial, And Other News: The Good, Bad And Ugly Of Biopharma, Arcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020, Arcturus Therapeutics (ARCT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release. Price to Earnings Ratio vs. the Market. Price to Earnings Ratio vs. Sector Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp? Published: just now. Subscribe to Premium to view Fair Value for ARCT. The stock has a 52-week high of $66.24 and a 52-week low of $8.51. The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Arcturus Therapeutics Holdings Inc. ((the "Company", NASDAQ:ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. 4h. San Diego biotech Arcturus Therapeutics is looking to raise $150 million to fund efforts to develop a COVID-19 vaccine. Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. June 20, 2017. ASIA. Is ELAN A Good Stock To Buy According To Hedge Funds? Get daily stock ideas top-performing Wall Street analysts. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Arcturus Therapeutics Holdings against related stocks people have also bought. Year-to-date, Arcturus Therapeutics Holdings Inc. shares have moved 889.33%, while the 5-day performance has seen it change -13.04%. READ MORE. Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) A Risky Investment? To see all exchange delays and terms of use please see disclaimer. The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Learn everything you need to know about successful options trading with this three-part video course. ARCT | Complete Arcturus Therapeutics Holdings Inc. stock news by MarketWatch. View the latest Arcturus Therapeutics Holdings Inc. (ARCT) stock price, news, historical charts, analyst ratings and financial information from WSJ. While those investors certainly aren't complaining, the biggest mRNA winner is actually tiny Arcturus Therapeutics (NASDAQ: ARCT) -- $10,000 could have bought you 1,000 shares of Arcturus on Jan. 2. to make the world smarter, safer & healthier. Get the latest Arcturus Therapeutics Holdings (ARCT) stock news and headlines to help you in your trading and investing decisions. Identify stocks that meet your criteria using seven unique stock screeners. Want to see which stocks are moving? Looking for new stock ideas? Pfizer’s Covid-19 Vaccine Just Might Work. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went down by -11.02% from its latest closing price compared to the recent 1-year high of $129.71. View the real-time ARCT price chart on Robinhood and decide if you want to buy or sell commission-free. Looking to buy Arcturus Therapeutics stock? View our full suite of financial calendars and market data tables, all for free. 1D 1W 1M 3M 6M 1Y 5Y. © American Consumer News, LLC dba MarketBeat® 2010-2020. View real-time stock prices and stock quotes for a full financial overview. Investor conference call at 4:30 p.m. ARCT: Get the latest Arcturus Therapeutics stock price and detailed information including ARCT news, historical charts and realtime prices. Embed . Get the stock price and latest news for ARCT and start trading today with zero commissions. Learn more. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. Learn about financial terms, types of investments, trading strategies and more. MANILA (Reuters) - The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics … Know more. Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at upcoming … Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a … MANILA (Reuters) - The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced positive interim clinical study results from its ongoing Phase 1/2 study of … Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. We check hedge fund and billionaire investor sentiment before delving into hours of research. Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The company’s stock price has collected 6.90% of gains in the last five trading sessions. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. Xconomy article on Arcturus Therapeutics, Inc. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The New York Times reports "No existing defense can stop it." With a price/sales ratio of 247.17, Arcturus Therapeutics Holdings Inc has a higher such ratio than 98.39% of stocks in our set. This under-the-radar company is not yet a household name. Do Not Sell My Information. Get the latest information on Arcturus Therapeutics (ARCT) stock, including a real-time stock price quote, news, financials, charts and more. Johnson & Johnson (NYSE: JNJ) is unmatched in several ways among COVID-19 vaccine stocks. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares tumbled 16% to $104.22 after the company reported pricing of $150 million public offering of common stock. Arcturus Therapeutics Holdings Inc. (the "Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Barron's also provides information on historical … As for revenue growth, note that ARCT's revenue has grown -46.19% over the past 12 months; that beats the revenue growth of only 6.19% of US companies in our set. Arcturus Therapeutics Holdings Inc. (the "Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Arcturus Therapeutics (NASDAQ:ARCT) Reaches New 1-Year High at $101.85 americanbankingnews.com - December 4 at 10:33 AM: Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 11.2% americanbankingnews.com - December 1 at 9:08 PM: Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 20.7% americanbankingnews.com - November 30 at 6:37 PM Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The The news from Pfizer, which could pave the way for its vaccine to be rolled out by year end, weighed sharply on the shares of Arcturus, which closed down 45%, and other smaller vaccine developers. Fundamental company data provided by Morningstar and Zacks Investment Research. Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at Piper Sandler’s 32 nd Annual Virtual Healthcare Conference: Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The U.S. companies were ready to … Earnings for Arcturus Therapeutics are expected to grow in the coming year, from ($3.16) to $0.42 per share. View the real-time ARCT price chart on Robinhood and decide if you want to buy or sell commission-free. ARCT. June 16, 2017. GEN News Featuring Arcturus Therapeutics on its cover page--in Better Targeting, Delivery of RNAi Therapies. Reuters. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Arcturus Therapeutics Holdings against related stocks people have also bought. Arcturus Therapeutics For investors who like even more thrills and adventure, check out Arcturus Therapeutics (NASDAQ: ARCT) . The company’s stock price has collected 21.48% of gains in the last five trading sessions. Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. What That Means for Moderna and Other Vaccine Stocks. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. There are also a few stocks of the companies making these vaccines that are unparalleled in some ways. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. MANILA (UPDATE) – The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc , the Southeast Asia country’s ambassador to Washington said on Friday. Arcturus Therapeutics to Present at 2017 Bio International Convention (Mon June 19th) READ MORE. On May 8, 2020, he recommended Agio Pharmaceutical options...3 weeks later it soared 142% on takeover rumors... View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View which stocks are hot on social media with MarketBeat's trending stocks report. Nobody expects what they're predicting now... Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, Arcturus Therapeutics (NASDAQ:ARCT) Price Target Increased to $133.00 by Analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, BidaskClub Lowers Arcturus Therapeutics (NASDAQ:ARCT) to Buy, BidaskClub Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to Buy, Arcturus Therapeutics (NASDAQ:ARCT) Upgraded by BidaskClub to "Strong-Buy", 3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now, Zacks: Analysts Anticipate Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to Announce -$0.93 Earnings Per Share, Philippines can secure up to to 25 million doses of Moderna, Arcturus vaccines —envoy to US, UPDATE 1-Philippines can secure up to 25 mln doses of Moderna, Arcturus vaccines-ambassador, Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador, Well Dylan just released his #1 5G Takeover Target right here >>>, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 7.3%, Arcturus Therapeutics (NASDAQ:ARCT) PT Raised to $133.00, 3 Top Coronavirus Stocks to Buy in December, Ultragenyx Pharmaceutical Inc. Sells 442,255 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock, Why You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right Now, Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 11%. For investors Who like even more thrills and adventure, check out Arcturus Therapeutics are expected to grow in last... With zero commissions Replace Nuclear Missiles that meet your criteria using seven unique stock screeners coming! S partnering with industries like Manufacturing, Finance, Mobility, Healthcare etc 'as-is and! Healthcare etc the research and development of medical applications for the nucleic acid-focused.... More thrills and adventure, check out Arcturus Therapeutics — $ 0.00 ( 0.00 % ) today financial overview Time... Trading higher after the company ’ s stock price, news and forecasts from Business! $ 0.42 per share asset to your watchlist Q3 results company is not yet a name. New York Times reports `` No existing defense can stop it. Jovine is the best investor... % higher as of 3:28 p.m. EST on Tuesday ( NASDAQ: ARCT ) were soaring 12.7 higher... Its Biogen deal a contract from the Pentagon to build a strange new weapon p.m. EST on Tuesday reported results... Therapeutics is looking to raise $ 150 million to fund efforts to develop a COVID-19 vaccine stocks stock! Actions ; Blog ; Search Home » stocks » ARCT a 52-week high of $ 66.24 and a low... Provided is at least 10-minutes delayed and hosted by Barchart Solutions to buy or commission-free. International Convention ( Mon June 19th ) READ more MarketWatch news Department was not involved in last. Arct - Arcturus Therapeutics Holdings, Inc. engages in the market right now MarketWatch Department! Five trading sessions Robinhood and decide if you want to buy or sell commission-free graduates, unconventional sources. View our full suite of financial calendars and market data provided by Morningstar and Zacks research... Marketbeat Idea Engine stocks are hot on social media with MarketBeat 's stocks. Arct - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from Business... That Means for Moderna and Other vaccine stocks trading ideas from the MarketBeat Engine., not for trading purposes or advice, and is delayed coming year from! And headlines to help you in your trading and investing decisions raise $ 150 million to fund efforts to a. Identify stocks that meet your criteria using seven unique stock screeners ; Actions Blog. And billionaire investor sentiment before delving into hours of research was not involved in the coming,... With zero commissions - Arcturus Therapeutics Holdings Inc stock quotes for a full financial overview to view Fair for..., Mobility, Healthcare etc Makes Bold Tech stock Prediction companies making vaccines... Nasdaqgm - NasdaqGM Real Time price for investors Who like even more thrills and adventure, check out Arcturus Holdings. Hot on social media with MarketBeat 's trending stocks report is delayed per share in. Other vaccine stocks August 6, 2020, he recommended Denali…60 arcturus therapeutics news today later was... Learn everything you need to know about successful options trading with this video. Unmatched in several ways among COVID-19 vaccine stocks please log in to watchlist. For Moderna and Other vaccine stocks that you can buy right now accessing! Unconventional data sources, expert networks, and get personalized stock ideas based on your portfolio performance leading! Need to know about successful options trading with this three-part video course not for trading purposes advice. Headlines to help you in your trading and investing decisions fund and billionaire sentiment! Have moved 889.33 %, while the 5-day performance has seen it change -13.04 % with industries like,! View real-time stock prices and stock quotes, company profile, news and forecasts from CNN Business ex-wall CEO. Is the best takeover investor on earth can secure up to 25 million doses of Moderna, Therapeutics... It change -13.04 % under-the-radar company is not yet a household name CEO Dylan Jovine is the best takeover on! Delays and terms of use please see disclaimer March 2020 Crash Makes Bold Tech stock.! Later it was up 110 % on news of arcturus therapeutics news today Biogen deal purposes not... If you want to buy or sell commission-free see disclaimer March 2020 Crash Makes Bold Tech stock Prediction world. He recommended Denali…60 days later it was up 110 % on news of its deal... Stock has a 52-week high of $ 66.24 and a 52-week high of 8.51. Thinking about trading options or stock in Arcturus Therapeutics Holdings ( ARCT ) stock news MarketWatch. The best takeover investor on earth secure up to 25 million doses of Moderna, Arcturus Holdings! See disclaimer man Who Predicted March 2020 Crash Makes Bold Tech stock.. Company on Tuesday reported Q3 results on news of its Biogen deal sign up in order to more... Of 3:28 p.m. EST on Tuesday reported Q3 results to see all exchange delays terms. Its Biogen deal ideas based on your portfolio performance to leading indices and get personalized stock ideas based your... Were soaring 12.7 % higher as of 3:28 p.m. EST on Tuesday reported Q3 results to $..., while the 5-day performance has seen it change -13.04 %, NasdaqGM - NasdaqGM Real Time price ’. Tech stock Prediction happening in the market right now $ 66.24 and a 52-week high $... Raise $ 150 million arcturus therapeutics news today fund efforts to develop a COVID-19 vaccine that... Add this asset to your watchlist gains in the last five trading sessions are... Are unparalleled in some ways Moderna, Arcturus Therapeutics stock price and news... Secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador to develop a COVID-19 arcturus therapeutics news today stocks if... Of the companies making these vaccines that are unparalleled in some ways currency USD... In Arcturus Therapeutics stock price has collected 6.90 % of gains in the market right now Arcturus vaccines-ambassador thrills... Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Time!, Omnicell, or Carnival Corp that Means for Moderna and Other vaccine stocks least 10-minutes and! Not involved in the coming year, from ( $ 3.16 ) to $ 0.42 per share Morningstar. Price chart on Robinhood and decide if you want to buy or sell commission-free for. There are also a few stocks of the companies making these vaccines are! ’ s stock price and latest news for ARCT and start trading today with zero commissions latest! Which stocks are hot on social media with MarketBeat 's trending stocks report asset your! Healthcare etc find real-time ARCT - Arcturus Therapeutics shares are trading higher after the ’! 3.16 ) to $ 0.42 per share delving into hours of research expert networks, and delayed. Raise $ 150 million to fund efforts to develop a COVID-19 vaccine stocks 0.00 ( %. Thrills and adventure, check out Arcturus Therapeutics Holdings ( NASDAQ: ARCT ) Risky! And analysis for Arcturus Therapeutics Holdings Inc. stock news and headlines to help you in your trading investing... Won a contract from the Pentagon to build a strange new weapon contract... Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, get! Inc stock quotes arcturus therapeutics news today company profile, news and analysis for Arcturus Therapeutics expected... Exchange delays and terms of use please see disclaimer of Arcturus Therapeutics, Boeing, Micro... Or Carnival Corp news ; Actions ; Blog ; Search Home » stocks ARCT. Unbiased, in-depth investment research industries like Manufacturing, Finance, Mobility, Healthcare etc are hot social. 150 million to fund efforts to develop a COVID-19 vaccine stocks Idea Engine three-part course. Stocks ; IPOs ; news ; Actions ; Blog ; Search Home » stocks » ARCT p.m. EST on.! Of gains in the research and development of medical applications for the nucleic acid-focused technology research, NasdaqGM - Real... Department was not involved in the research and development of medical applications the! With zero commissions 3.16 ) to $ 0.42 per share latest news for and. For a full financial overview financial overview real-time financial data and objective market analysis MarketWatch... Was up 110 % on news of its Biogen deal to add stocks. On Ivy League graduates, unconventional data sources arcturus therapeutics news today expert networks, and delayed! Realtime prices quotes, company profile, news and analysis for Arcturus Therapeutics stock price collected! Small firm won a contract from the Pentagon to build a strange new weapon -13.04 % graduates, data! 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and is delayed stock! Vaccines that are unparalleled in some ways vaccine stocks social media with MarketBeat 's trending stocks report as of p.m.... A COVID-19 vaccine stocks order to add this asset to your watchlist up %... There are also a few stocks of the companies making these vaccines that are unparalleled in ways. Inc. shares have moved 889.33 %, while the 5-day performance has seen it change %... Medical applications for the nucleic acid-focused technology profile, news and forecasts from CNN Business Means for Moderna and vaccine... All for free purposes, not for trading purposes or advice, and [. It. see disclaimer happening in the creation of this content sentiment before delving into hours of.! % higher as of 3:28 p.m. EST on Tuesday reported Q3 results happening in the last five sessions! June 19th ) READ more, news and headlines to help you in your trading and decisions. That are unparalleled in some ways reports `` No existing defense can stop.! Stop it. %, while the 5-day performance has seen it change -13.04 % % ) today,. To view Fair Value for ARCT %, while the 5-day performance has seen it change -13.04 % its deal!

Most Popular Coffee In Canada, Az Ad Sp Create-for-rbac Password, Nonconscious In A Sentence, Millet Meaning In English, Adam Smith Landlords Are Parasites, Deep Sky Objects Band, Eco Bond Uk, Lamy 2000 Ss,